Health and Pharmaceutical Litigation

Our lawyers have prosecuted numerous successful actions to recover monetary damages  pursuant to section 8 of the PM(NOC) Regulations, with cumulative recovery for our clients in the hundreds of millions of dollars.  Through this work, our lawyers have developed a vast network of contacts in forensic accounting and economics, who also assist our clients in defending against claims for monetary remedies for patent infringement.  Our lawyers have been at the forefront of developing a principled, modern and sophisticated approach to assessing remedies for patent infringement in Canada.

When it comes to navigating the regulatory approval process for pharmaceuticals, Goodmans has more experience than any other firm addressing and successfully challenging the decisions of Health Canada, including by way of judicial review.  After market approval, our lawyers have assisted pharmaceutical clients in high-stakes, “bet the company” challenges to regulatory decisions imperiling their ability to market their products in Canada.  In addition, when regulatory decisions have caused our clients to suffer monetary damage, we have successfully acted in litigation to recover very significant remedies from the government.

Given our deep understanding of the Canadian and international pharmaceutical markets, we also advise pharmaceutical clients regarding pricing regulations and best practices before the Patented Medicines Prices Review Board (PMPRB), including hearings before the PMPRB.  When trademark issues arise in the pharmaceutical industry, our lawyers have also consistently been called upon, resulting in precedential jurisprudence.

Our lawyers also regularly defend high-stakes product liability class actions in the pharmaceutical industry.